[1] 罗黎力, 陈大鹏, 屈艺, 等. 早产儿218例视网膜病变筛查分析[J].中华实用儿科临床杂志, 2013,28(14):1058-1060. Luo LL,Chen DP,Qu Y, et al.Analysis of 218 cases of retinopathy of prematurity[J].Chin J Appl Clin Pediatr, 2013,28(14):1058-1060. [2] Quinn JA, Munoz FM, Gonik B, et al. Preterm birth:Case definition & guidelines for data collection, analysis, and presentation of immunisation safety data[J]. Vaccine, 2016,34(49):6047-6056. [3] 张巍, 尹虹, 黎晓新, 等. 早产儿视网膜病筛查管理及成本效益分析[J].中华医院管理杂志, 2006,22(9):644-646. Zhang W,Yin H,Li XX,et al.Screening management and cost-benefit analysis of retinopathy of prematurity[J]. Chin J Hosp Admin,2006,22(9):644-646. [4] 国家卫生和计划生育委员会. "十三五"全国眼健康规划(2016—2020年)[J]. 中华眼科杂志, 2017,53(7):484-486. National Health Commission."13th Five-Year" national eye health plan(2016-2020)[J].Chin J Ophthalmol,2017,53(7):484-486. [5] 黎晓新.中国早产儿视网膜病变筛查指南(2014年)[J].中华眼科杂志, 2014,50(12):933-935. Li XX.Chinese screening guidelines for retinopathy of prematurity(2014)[J].Chin J Ophthalmol,2014,50(12):933-935. [6] 周也群, 陈超, 陈露, 等. 中国大陆早产儿视网膜病变临床特点和眼底病变的多中心调查[J].中国循证儿科杂志, 2015,10(3):161-165. Zhou YQ,Chen C,Chen L,et al.Multicenter survey on the clinical features and fundus lesions of retinopathy in premature infants in mainland China[J].Chin J Evid Based Pediatr, 2015,10(3):161-165. [7] Ozcan PY. Retinopathy of prematurity among syrian refugees:Incidence and severity[J]. Middle East Afr J Ophthalmol, 2019,26(1):7-10. [8] Arnesen L, Duran P, Silva J, et al. A multi-country, cross-sectional observational study of retinopathy of prematurity in Latin America and the Caribbean[J]. Rev Panam Salud Publica, 2016,39(6):322-329. [9] Wu C, Lofqvist C, Smith LE, et al. Importance of early postnatal weight gain for normal retinal angiogenesis in very preterm infants:A multicenter study analyzing weight velocity deviations for the prediction of retinopathy of prematurity[J]. Arch Ophthalmol, 2012,130(8):992-999. [10] 黎作为, 冯小志, 黎容, 等. 早产儿视网膜病变高危因素分析[J]. 国际眼科杂志, 2021,21(12):2187-2190. Li ZW,Feng XZ,Li R,et al.High risk factors of retinopathy of prematurity[J].Int Eye Sci,2021,21(12):2187-2190. [11] 卢敏凤,杨丽莉.早产儿视网膜病变发生的危险因素分析[J]. 中国妇幼保健, 2021,36(16):3801-3803. Lu MF,Yang LL.Analysis of the risk factors for the development of retinopathy of prematurity[J].Maternal and Child Health Care of China,2021,36(16):3801-3803. [12] 雷春燕, 雷博. 眼科新一代抗血管内皮生长因子药物的基础研究及临床试验进展[J].中华实验眼科杂志,2014,32(10):938-942. Lei CY,Lei B.Basic research and clinical trial progress of the new generation of anti-vascular endothelial growth factor drugs in ophthalmology[J].Chin J Exp Ophthalmol, 2014, 32(10):938-942. [13] 李翠洁, 叶天航, 邹毅, 等. 早产儿视网膜病变的发病机制研究进展[J].湖北民族学院学报(医学版),2018,35(1):63-66. Li CJ,Ye TH,Zou Y,et al. Advances in the pathogenesis of retinopathy of prematurity[J].Journal of Hubei University for Nationalities(Medical Edition), 2018,35(1):63-66. [14] 王珍, 鲁曦婷, 李之喆, 等. 苏州市立医院本部3471例新生儿中ROP患病情况分析[J]. 国际眼科杂志, 2018,18(3):572-574. Wang Z,Lu XT,Li ZZ,et al.Prevalence of ROP in 3471 premat infants in Suzhou Municipal Hospital[J].Int Eye Sci,2018,18(3):572-574. [15] 中华医学会儿科学分会眼科学组. 早产儿视网膜病变治疗规范专家共识[J]. 中华眼底病杂志, 2022,38(1):10-13. Ophthalmology Group of Pediatrics Society of Chinese Medical Association.Expert consensus on the treatment of retinopathy of prematurity[J]. Chin J Ocular Fundus Dis,2022,38(1):10-13. [16] 孙娜, 陈垂海, 杨瑰艳, 等. 三亚地区早产儿视网膜病变流行现状及其母亲相关因素分析[J]. 国际眼科杂志,2021,21(3):500-504. Sun N,Chen CH,Yang GY,et al.Prevalence of retinopathy of prematurity in Sanya and analysis of its maternal related factors[J]. Int Eye Sci, 2021,21(3):500-504. [17] 王宇,周晓光, 陈志均. 早产儿视网膜病治疗研究进展[J]. 中华实用儿科临床杂志,2017,32(2):146-148. Wang Y,Zhou XG,Chen ZJ.Advances in the treatment of retinopathy of prematurity[J].Chin J Appl Clin Pediatr, 2017, 32(2):146-148. |